Copenhagen, 2016-06-09 10:46 CEST (GLOBE NEWSWIRE) -- Exiqon A/S (Nasdaq Copenhagen: “EXQ”) calls for the ordinary general meeting to be held on Tuesday 5 July 2016 at 10.00 am at Bech-Bruun’s address at Langelinie Allé 35, 2100 Copenhagen, Denmark. A copy of the notice with the complete proposals is attached hereto and can also be seen at www.exiqon.com.
Additional information
Lars Kongsbak, CEO, phone +45 4566 0888 (cell: +45 4090 2101)
Hans Henrik Chrois Christensen, CFO, phone +45 4566 0888 (cell: +45 4090 2131)
About Exiqon
At Exiqon, we advance the research of when and where genes are expressed. We empower scientists across the world with best-in-class products and user-friendly business solutions designed to transform workflows in our industry. Exiqon operates in two business areas: Exiqon Life Sciences is a leading provider of flexible solutions for gene expression analysis. Academia, biotech and pharmaceutical companies around the world use Exiqon’s research products to make ground-breaking discoveries. Exiqon Diagnostics collaborates with diagnostic and pharmaceutical companies to develop novel molecular diagnostic tests for early detection of diseases, which can help physicians make better treatment decisions. Exiqon is listed on Nasdaq Copenhagen. For more information about us, please visit www.exiqon.com
